Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
InChi: InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3
4)33)26-13-14-27-23(10-7-16-30(26
Smiles: COC1=CC=C(C=C1)C1=CC2=C(N=CN=C2N)O1
C1NCC2CC1C1=CC3=NC=CN=C3C=C12
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor
RS 09 Catalog No.:M25681-C InChi: InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3RS09 is a LPS peptide mimic serves as a candidate to be considered as a new class of TLR4 agonist adjuvant. RS09 increases antibody production in a vaccine setting. Product information CAS Number: 1449566 36 2 Molecular Weight: 691. 78 Formula: C31H49N9O9 Chemical Name: (2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 {[(2S) 1 [(2S) 1 [(2S) 2 aminopropanoyl]pyrrolidine 2 carbonyl]pyrrolidin 2 yl]formamido} 3 (1H imidazol 5 yl)propanamido]propanamido] 4
US$ 8750.00
US$ 172.00
US$ 38.00
US$ 72.00
US$ 52.00
US$ 4000.00
US$ 38.00
US$ 6250.00
US$ 8500.00
US$ 85.00
US$ 52.00
US$ 38.00